慢性移植物抗宿主病的抗白血病效应：对异基因骨髓移植后生存率提高的贡献。 - Suppr

Suppr

超能文献

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

作者信息

Weiden P L, Sullivan K M, Flournoy N, Storb R, Thomas E D

出版信息

N Engl J Med. 1981 Jun 18;304(25):1529-33. doi: 10.1056/NEJM198106183042507.

DOI:10.1056/NEJM198106183042507

PMID:7015133

Abstract

摘要

相似文献

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.慢性移植物抗宿主病的抗白血病效应：对异基因骨髓移植后生存率提高的贡献。

N Engl J Med. 1981 Jun 18;304(25):1529-33. doi: 10.1056/NEJM198106183042507.

Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.异基因骨髓移植受者中移植物抗宿主病的抗白血病效应

N Engl J Med. 1979 May 10;300(19):1068-73. doi: 10.1056/NEJM197905103001902.

The status of bone marrow transplantation for leukemia.

Hosp Pract (Off Ed). 1985 Nov 15;20(11):97-110. doi: 10.1080/21548331.1985.11703190.

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.异基因骨髓移植后的长期生存与晚期死亡。国际骨髓移植登记处迟发效应工作委员会。

N Engl J Med. 1999 Jul 1;341(1):14-21. doi: 10.1056/NEJM199907013410103.

Leukemia relapse after allogeneic bone marrow transplantation: how does chronic graft-versus-host disease influence the pattern and onset of relapse?

Exp Clin Transplant. 2011 Dec;9(6):432-3.

Allogeneic bone marrow transplantation in leukemia.白血病中的异基因骨髓移植。

Recent Results Cancer Res. 1984;93:269-89. doi: 10.1007/978-3-642-82249-0_12.

Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.环磷酰胺、阿糖胞苷和全身照射作为白血病患者异基因骨髓移植的预处理方案。

Bone Marrow Transplant. 1999 Jun;23(11):1095-100. doi: 10.1038/sj.bmt.1701786.

Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation.

Transplant Proc. 1981 Mar;13(1 Pt 1):248-51.

Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.使用供体淋巴细胞进行异基因细胞介导的免疫疗法，以预防接受异基因骨髓移植治疗血液系统恶性肿瘤的患者复发。

Clin Transpl. 1996:281-90.

Allogeneic bone marrow transplantation.异基因骨髓移植

Crit Rev Clin Lab Sci. 1983;19(3):173-86. doi: 10.3109/10408368309165762.

引用本文的文献

Optimal GVHD Prophylaxis.最佳移植物抗宿主病预防措施

Adv Exp Med Biol. 2025;1475:77-102. doi: 10.1007/978-3-031-84988-6_5.

Reduced incidence of relapse and graft--host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后急性髓系白血病复发率及移植物抗宿主病发生率降低。

Haematologica. 2025 Sep 1;110(9):1998-2008. doi: 10.3324/haematol.2025.287390. Epub 2025 Apr 10.

Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect.AML 中的调理和移植后维持的创新：关于移植物抗白血病效应的基于基因组信息的揭示。

Front Immunol. 2024 Mar 20;15:1359113. doi: 10.3389/fimmu.2024.1359113. eCollection 2024.

The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy.移植物抗白血病效应：供者淋巴细胞输注和细胞治疗。

Front Immunol. 2024 Mar 15;15:1328858. doi: 10.3389/fimmu.2024.1328858. eCollection 2024.

Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?2024年病程记录：治愈艾滋病病毒；是我有生之年无法实现还是指日可待？

Pathog Immun. 2024 Mar 1;8(2):115-157. doi: 10.20411/pai.v8i2.665. eCollection 2023.

Novel therapies for graft versus host disease with a focus on cell therapies.新型移植物抗宿主病治疗方法，重点是细胞疗法。

Front Immunol. 2023 Oct 5;14:1241068. doi: 10.3389/fimmu.2023.1241068. eCollection 2023.

Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation.微小型急性移植物抗宿主病改善了移植后环磷酰胺和脐血移植后 HLA 单倍体相关供者移植的预后。

Cell Transplant. 2023 Jan-Dec;32:9636897231194497. doi: 10.1177/09636897231194497.

Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress.急性白血病的免疫疗法：过去的成功为未来的进展铺平道路。

Cancers (Basel). 2023 Aug 17;15(16):4137. doi: 10.3390/cancers15164137.

The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease.异基因干细胞移植后预防性供者淋巴细胞输注的移植物抗白血病效应在预防复发方面同样有效，但与自发性移植物抗宿主病相比更安全。

Ann Hematol. 2023 Sep;102(9):2529-2542. doi: 10.1007/s00277-023-05276-5. Epub 2023 Jul 25.

Role of Gut Microbiota and Oxidative Stress in the Progression of Transplant-Related Complications following Hematopoietic Stem Cell Transplantation.肠道微生物群和氧化应激在造血干细胞移植后移植相关并发症进展中的作用。

Oxid Med Cell Longev. 2023 Apr 18;2023:3532756. doi: 10.1155/2023/3532756. eCollection 2023.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验